BRCA2 and breast cancer: Similarly, Kuchenbaecker et al. found that breast cancer and ovarian cancer PGS are significantly associated with cancer risk even in BRCA1 and BRCA2 LEV carriers, suggesting a role for PGS in cancer risk management20.